Saudi share "Al -Mousa Health" is 15% in the first days of its circulation

The shares of Al -Mousa Health Company rose by about 15%as it rose to 146 Riyals after it closed from the initial offering price of 127 Riyals, in the first trade session in the Saudi financial market today, Tuesday. The first public offer of a 30% stake in the company was attracted in December’s requests of 173 billion Riyals of investment institutions at a coverage rate of 103 times. The offer was a few minutes after the subscription door was opened, which became a feature of most public subscriptions in the Gulf, as seen by the initial offer of the “Talabat” business in Dubai and “Dr. Sulaiman Abdul Qadir Fakih Hospital Company” in the Kingdom. At the same time, the individual segment, which is the least in supply, also attracted requests of 1.4 billion Riyals, with a coverage of 408%. Al -Mousa’s health subscription has driven the founder of the company “Abdel Aziz Al -Mousa” on the list of billionaires as its wealth is estimated at about $ 915 million through its indirect share in the company and the return of part of the shares by selling the offer, and rising to 1.12 billion with the addition of a 5%, with the addition of a 5%. Shares he has distributed on the past four years. According to the reports of the “East” and the company, the importance transferred to a charity in the name of the family is. The subscription activity in Saudi Arabia is the most active market for the Middle East in terms of stock proposals over the past year, as companies have collected more than 16.8 billion dollars, according to the Bloomberg collected, supported by the large secondary offer of Saudi Aramco in May. The kingdom, like the rest of the wave states, seeks to diversify its financial market, dominated by banks and industrial enterprises. The healthcare sector is an essential pillar in the plan of Crown Prince Mohammed Bin Salman for the economic transformation “Vision 2030”, which expects to grow in the population and an increase in average life expectancy. The Kingdom was witness to a series of infections in this sector, including the Middle East Pharmaceutical Industries, and the company “Dr. Sulaiman Abdel Qader Fakih”. It should be noted that the Saudi public investment fund plans to include ‘Nobco’, the largest medical purchase business in the kingdom, according to ‘Bloomberg’ previously reported.